Acute Leukemia Presentation with DIC

  • Laurie A. MankaEmail author
  • Kenneth Lyn-Kew


Disseminated intravascular coagulation (DIC) is a common disorder in the ICU. It is often seen in the setting of Acute Myelocytic leukemia, and specifically Acute Promyelocytic Leukemia. The key points in care of the patient with DIC in the ICU are early diagnosis of the coagulation abnormality and treatment directed at the underlying cause. Supportive care with blood product transfusion may also be necessary.


AML APML DIC Thrombocytopenia T(15;17) ATRA 


  1. 1.
    Warrell RP, De The H, Zhen-Yi W, Degos L. Acute promyelocytic leukemia. N Engl J Med. 2002;329:177–89.CrossRefGoogle Scholar
  2. 2.
    Sarris AN, Kempin S, Berman E, et al. High incidence of disseminated intravascular coagulation during remission induction of adult patients with acute lymphoblastic leukemia. Blood. 1992;79:1305–10.CrossRefGoogle Scholar
  3. 3.
    Colman RW, Rubin RN. Disseminated intravascular coagulation due to malignancy. Semin Oncol. 1990;17:172–86.PubMedGoogle Scholar
  4. 4.
    Francis RB Jr, Seyfert U. Tissue plasminogen activator antigen and activity in disseminated intravascular coagulation: clinicopathologic correlations. J Lab Clin Med. 1987;110:541–7.PubMedGoogle Scholar
  5. 5.
    Bennett B, Booth NA, Croll A, et al. The bleeding disorder in acute promyelocytic leukemia: fibrinolysis due to u-TPA rather than defibrination. Br J Haematol. 1989;71:511–7.CrossRefGoogle Scholar
  6. 6.
    Falanga A, Consonni R, Marchetti M, et al. Cancer procoagulant in the human promyelocytic cell line NB4 and its modulation by all-trans-retinoic-acid. Leukemia. 1988;8:156–9.Google Scholar
  7. 7.
    DeStefano V, Teofili L, Sica S, et al. Effect of all-trans retinoic acid on procoagulant and fibrinolytic activities of cultured blast cells from patients with acute promyelocytic leukemia. Blood. 1995;86:3535–41.CrossRefGoogle Scholar
  8. 8.
    Dores GM, et al. Acute leukemia incidence and patient survival among children and adults in the United States, 2001–2007. Blood. 2012;119:34–43.CrossRefGoogle Scholar
  9. 9.
    Levi M. Disseminated intravascular coagulation; what’s new. Crit Care Clin. 2005;21:449–67.CrossRefGoogle Scholar
  10. 10.
    O’Shaughnessy DF, Atterbury C, Boton Maggs P, et al. Guidelines for the use of fresh frozen plasma, cryoprecipate and cryosupernatant. Br J Haematol. 2004;126:11.CrossRefGoogle Scholar
  11. 11.
    Wada H, Matsumoto T, Yamashita Y. Diagnosis and treatment of disseminated intravascular coagulation (DIC) according to four DIC guidelines. J Intensive Care. 2014;2:15.CrossRefGoogle Scholar
  12. 12.
    Warren BL, Eid A, Singer P, et al. High-dose antithrombin III in severe sepsis. JAMA. 2001;286:1869–78.CrossRefGoogle Scholar
  13. 13.
    Zver S, Andoljsek D, Cernelc P. Effective treatment of life-threatening bleeding with recombinant activated factor VII in a patient with acute promyelocytic leukaemia. Eur J Haematol. 2004;72:455–6.CrossRefGoogle Scholar
  14. 14.
    Alimoghaddam K, Ghavamzadeh A, Jahani M. Use of NovoSeven for arsenic trioxide-induced bleeding in PML. Am J Hematol. 2006;81:720.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Division of Pulmonary, Critical Care and Sleep Medicine, Department of MedicineNational Jewish HealthDenverUSA

Personalised recommendations